Factor xiii substitution in surgical cancer patients at high risk for intraoperative bleeding

Anesthesiology

Volumn 110, Issue 2, 2009, Pages 239-245

  Korte, Wolfgang C ^a   Szadkowski, Christine ^b   Gähler, Anita ^a   Gabi, Konrad ^b   Kownacki, Edward ^b   Eder, Monika ^a   Degiacomi, Priska ^a   Zoller, Norbert ^a   Devay, Jan ^b   Lange, Jochen ^c   Schnider, Thomas ^b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b KANTONSSPITAL   (Switzerland)

^c Head of Clinical Marketing CSL Behring   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; PLACEBO; CRYSTALLOID SOLUTIONS; ISOTONIC SOLUTION; PLASMA SUBSTITUTE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BLOOD CLOTTING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOTENSION; INTRAOPERATIVE PERIOD; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; TREATMENT PLANNING; BLOOD; ERYTHROCYTE TRANSFUSION; MIDDLE AGED; NEOPLASM; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PHYSIOLOGY; PROSPECTIVE STUDY; SAMPLE SIZE; THROMBOELASTOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FACTOR XIII; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; NEOPLASMS; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; SAMPLE SIZE; THROMBELASTOGRAPHY; TREATMENT OUTCOME;

EID: 61549127913     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318194b21e     Document Type: Article

References (26)

1. Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T: Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer. Eur J Surg 2002; 168:229-35
2. Forshaw MJ, Gossage JA, Stephens J, Strauss D, Botha AJ, Atkinson S, Mason RC: Centralisation of oesophagogastric cancer services: can specialist units deliver? Ann R Coll Surg Engl 2006; 88:566-70
3. Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, Schnider T, Korte W: Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004; 99:1564-9
4. Korte W, Gabi K, Rohner M, Gahler A, Szadkowski C, Schnider TW, Lange J, Riesen W: Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery. Thromb Haemost 2005; 94:211-5
5. Hosaka A, Miyata T, Aramoto H, Shigematsu H, Nakazawa T, Okamoto H, Shigematsu K, Nagawa H: Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm. J Vasc Surg 2005; 42:200-5
6. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD: Elective bowel resection for incurable stage IV colorectal cancer: Prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196:722-8
7. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999; 6:790-6
8. Brown JV, Karlan BY, Greenspoon JS, Rosove MH, Lagasse LD: Perioperative coagulopathy in patients undergoing primary cytoreduction. Cancer 1993; 71: 2557-61
9. Turrini O, Moutardier V, Guiramand J, Lelong B, Bories E, Sannini A, Magnin V, Viret F, Blache JL, Giovannini M, Delpero JR: Hemorrhage after duodenopancreatectomy: Impact of neoadjuvant radiochemotherapy and experience with sentinel bleeding. World J Surg 2005; 29:212-6
10. Nagino M, Kamiya J, Arai T, Nishio H, Ebata T, Nimura Y: One hundred consecutive hepatobiliary resections for biliary hilar malignancy: Preoperative blood donation, blood loss, transfusion, and outcome. Surgery 2005; 137:148-55
11. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V: Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: Implications of a prospective study. Stroke 2002; 33:1618-23
12. Korte W, Hinnen C, Degiacomi P, Lussmann R: Relevant F. XIII deficiency in the surgical intensive care unit is more frequent than a relevant fibrinogen deficiency. Haemostaseologie 2007; 27:A61
13. Gando S, Kamiya K, Makise H, Tedo I, Nakanishi Y: [Wound healing, blood coagulation and fibrinolysis during operations involving gastric cancer surgery]. Nippon Geka Gakkai Zasshi 1989; 90:59-63
14. Brockmeier SJ, Schwub D, Gloddek B: [Is the use of factor XIII for delayed wound healing in patients with head-neck tumors of value?]. Laryngorhinootologie 1998; 77:715-8
15. Rasche H, Haghou F, Gaus W, Dietrich M, Hoelzer D, Pflieger H, Kurrle E, Pindur G, Seifried E, Heimpel H: [Blood clotting factor XIII substitution in acute leukaemia: Result of a randomized and controlled study]. Dtsch Med Wochenschr 1982; 107:1882-6
16. Sakuma H, Satoh T, Matsumoto E, Kanno H, Watanabe M, Kikuta A, Suzuki H: [The clinical effect of factor XIII on drug-induced hemorrhagic cystitis]. Rinsho Ketsueki 1994; 35:279-85
17. Mortelmans YJ, Vermaut GA, Van Aken H: A simple method for calculating component dilution during fluid resuscitation: The Leuven approach. J Clin Anesth 1994; 6:279-87
18. Korte W: [Fibrin monomer and factor XIII: A new concept for unexplained intraoperative coagulopathy]. Hamostaseologie 2006; 26:S30-5
19. Mosesson MW, Siebenlist KR, Hernandez I, Lee KN, Christiansen VJ, McKee PA: Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: A new role for plasma factor XIII in fibrinolysis regulation. J Thromb Haemost 2008; 6:1565-70
20. Chandler WL, Patel MA, Gravelle L, Soltow LO, Lewis K, Bishop PD, Spiess BD: Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagul Fibrinolysis 2001; 12:101-8
21. Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H: Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54:26-33
22. Nielsen VG: Colloids decrease clot propagation and strength: Role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005; 49:1163-71
23. Nielsen VG, Gurley WQ, Jr., Burch TM: The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004; 99:120-3
24. Reynolds TC, Butine MD, Visich JE, Gunewardena KA, MacMahon M, Pederson S, Bishop PD, Morton KM: Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers. J Thromb Haemost 2005; 3:922-8
25. Lovejoy AE, Reynolds TC, Visich JE, Butine MD, Young G, Belvedere MA, Blain RC, Pederson SM, Ishak LM, Nugent DJ: Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006; 108:57-62
26. Visich JE, Zuckerman LA, Butine MD, Gunewardena KA, Wild R, Morton KM, Reynolds TC: Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study. Thromb Haemost 2005; 94:802-7